Skip to main content
. 2022 Aug 27;13(3):942–954. doi: 10.1016/j.apsb.2022.08.015

Figure 6.

Figure 6

Biocompatibility test of nanoparticles in vitro and in vivo. (A) Toxicity test of liposome/mRNA complexes in DC2.4 cells. (B,C) Liver function assay of mice with different treatments. (D–F) Renal function assay of mice with different treatments. Data are presented as mean ± SD (n = 3). ∗P < 0.005. ∗∗∗P < 0.001. (G) H&E staining of heart, liver, spleen, lung and kidney pathology 10 days after the initial immunization (scale bar = 200 μm).